192 related articles for article (PubMed ID: 37880218)
1. Chromatin accessibility landscape of relapsed pediatric B-lineage acute lymphoblastic leukemia.
Wang H; Sun H; Liang B; Zhang F; Yang F; Cui B; Ding L; Wang X; Wang R; Cai J; Tang Y; Rao J; Hu W; Zhao S; Wu W; Chen X; Wu K; Lai J; Xie Y; Li B; Tang J; Shen S; Liu Y
Nat Commun; 2023 Oct; 14(1):6792. PubMed ID: 37880218
[TBL] [Abstract][Full Text] [Related]
2. Analysis of Ig and T-cell receptor genes in 40 childhood acute lymphoblastic leukemias at diagnosis and subsequent relapse: implications for the detection of minimal residual disease by polymerase chain reaction analysis.
Beishuizen A; Verhoeven MA; van Wering ER; Hählen K; Hooijkaas H; van Dongen JJ
Blood; 1994 Apr; 83(8):2238-47. PubMed ID: 8161789
[TBL] [Abstract][Full Text] [Related]
3. DNA microarrays for comparison of gene expression profiles between diagnosis and relapse in precursor-B acute lymphoblastic leukemia: choice of technique and purification influence the identification of potential diagnostic markers.
Staal FJ; van der Burg M; Wessels LF; Barendregt BH; Baert MR; van den Burg CM; van Huffel C; Langerak AW; van der Velden VH; Reinders MJ; van Dongen JJ
Leukemia; 2003 Jul; 17(7):1324-32. PubMed ID: 12835720
[TBL] [Abstract][Full Text] [Related]
4. Evolution of the Epigenetic Landscape in Childhood B Acute Lymphoblastic Leukemia and Its Role in Drug Resistance.
Saint Fleur-Lominy S; Evensen NA; Bhatla T; Sethia G; Narang S; Choi JH; Ma X; Yang JJ; Kelly S; Raetz E; Harvey RC; Willman C; Loh ML; Hunger SP; Brown PA; Getz KM; Meydan C; Mason CE; Tsirigos A; Carroll WL
Cancer Res; 2020 Dec; 80(23):5189-5202. PubMed ID: 33067268
[TBL] [Abstract][Full Text] [Related]
5. Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients.
Scheijen B; Boer JM; Marke R; Tijchon E; van Ingen Schenau D; Waanders E; van Emst L; van der Meer LT; Pieters R; Escherich G; Horstmann MA; Sonneveld E; Venn N; Sutton R; Dalla-Pozza L; Kuiper RP; Hoogerbrugge PM; den Boer ML; van Leeuwen FN
Haematologica; 2017 Mar; 102(3):541-551. PubMed ID: 27979924
[TBL] [Abstract][Full Text] [Related]
6. Profiling chromatin accessibility in pediatric acute lymphoblastic leukemia identifies subtype-specific chromatin landscapes and gene regulatory networks.
Diedrich JD; Dong Q; Ferguson DC; Bergeron BP; Autry RJ; Qian M; Yang W; Smith C; Papizan JB; Connelly JP; Hagiwara K; Crews KR; Pruett-Miller SM; Pui CH; Yang JJ; Relling MV; Evans WE; Savic D
Leukemia; 2021 Nov; 35(11):3078-3091. PubMed ID: 33714976
[TBL] [Abstract][Full Text] [Related]
7. Nucleotide excision repair is a predictor of early relapse in pediatric acute lymphoblastic leukemia.
Ibrahim OM; As Sobeai HM; Grant SG; Latimer JJ
BMC Med Genomics; 2018 Oct; 11(1):95. PubMed ID: 30376844
[TBL] [Abstract][Full Text] [Related]
8. Deep targeted sequencing in pediatric acute lymphoblastic leukemia unveils distinct mutational patterns between genetic subtypes and novel relapse-associated genes.
Lindqvist CM; Lundmark A; Nordlund J; Freyhult E; Ekman D; Carlsson Almlöf J; Raine A; Övernäs E; Abrahamsson J; Frost BM; Grandér D; Heyman M; Palle J; Forestier E; Lönnerholm G; Berglund EC; Syvänen AC
Oncotarget; 2016 Sep; 7(39):64071-64088. PubMed ID: 27590521
[TBL] [Abstract][Full Text] [Related]
9. Aneuploidy in childhood B cell acute lymphoblastic leukaemia - also a relevant prognostic factor in relapsed disease?
Zugmaier G
Br J Haematol; 2019 Mar; 184(6):895-896. PubMed ID: 30723892
[No Abstract] [Full Text] [Related]
10. Pediatric-Like Acute Lymphoblastic Leukemia Therapy in Adults With Lymphoblastic Lymphoma: The GRAALL-LYSA LL03 Study.
Lepretre S; Touzart A; Vermeulin T; Picquenot JM; Tanguy-Schmidt A; Salles G; Lamy T; Béné MC; Raffoux E; Huguet F; Chevallier P; Bologna S; Bouabdallah R; Benichou J; Brière J; Moreau A; Tallon-Simon V; Seris S; Graux C; Asnafi V; Ifrah N; Macintyre E; Dombret H
J Clin Oncol; 2016 Feb; 34(6):572-80. PubMed ID: 26644537
[TBL] [Abstract][Full Text] [Related]
11. Enhancer retargeting of CDX2 and UBTF::ATXN7L3 define a subtype of high-risk B-progenitor acute lymphoblastic leukemia.
Kimura S; Montefiori L; Iacobucci I; Zhao Y; Gao Q; Paietta EM; Haferlach C; Laird AD; Mead PE; Gu Z; Stock W; Litzow M; Rowe JM; Luger SM; Hunger SP; Ryland GL; Schmidt B; Ekert PG; Oshlack A; Grimmond SM; Rehn J; Breen J; Yeung D; White DL; Aldoss I; Jabbour EJ; Pui CH; Meggendorfer M; Walter W; Kern W; Haferlach T; Brady S; Zhang J; Roberts KG; Blombery P; Mullighan CG
Blood; 2022 Jun; 139(24):3519-3531. PubMed ID: 35192684
[TBL] [Abstract][Full Text] [Related]
12. Chromatin accessibility landscape of pediatric T-lymphoblastic leukemia and human T-cell precursors.
Erarslan-Uysal B; Kunz JB; Rausch T; Richter-Pechańska P; van Belzen IA; Frismantas V; Bornhauser B; Ordoñez-Rueada D; Paulsen M; Benes V; Stanulla M; Schrappe M; Cario G; Escherich G; Bakharevich K; Kirschner-Schwabe R; Eckert C; Loukanov T; Gorenflo M; Waszak SM; Bourquin JP; Muckenthaler MU; Korbel JO; Kulozik AE
EMBO Mol Med; 2020 Sep; 12(9):e12104. PubMed ID: 32755029
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of gene expression in relapsed childhood B-acute lymphoblastic leukemia.
Chow YP; Alias H; Jamal R
BMC Cancer; 2017 Feb; 17(1):120. PubMed ID: 28183295
[TBL] [Abstract][Full Text] [Related]
14. Integrated analysis of relapsed B-cell precursor Acute Lymphoblastic Leukemia identifies subtype-specific cytokine and metabolic signatures.
Schroeder MP; Bastian L; Eckert C; Gökbuget N; James AR; Tanchez JO; Schlee C; Isaakidis K; Häupl B; Baum K; Migueles Lozano OA; Kouidri K; Pan KT; Urlaub H; Schwartz S; Burmeister T; von Stackelberg A; Hoelzer D; Pfeiffer H; Rieger MA; Göllner S; Oellerich T; Horstman M; Schrappe M; Wolf J; Kirschner-Schwabe R; Brüggemann M; Müller-Tidow C; Serve H; Neumann M; Baldus CD
Sci Rep; 2019 Mar; 9(1):4188. PubMed ID: 30862934
[TBL] [Abstract][Full Text] [Related]
15. Copy Number Alterations are Associated with the Risk of Very Early Relapse in Pediatric B-lineage Acute Lymphoblastic Leukemia: A Nested Case-control MIGICCL Study.
Rosales-Rodríguez B; Núñez-Enríquez JC; Velázquez-Wong AC; González-Torres C; Gaytán-Cervantes J; Jiménez-Hernández E; Martín-Trejo JA; Campo-Martínez MLÁD; Medina-Sanson A; Flores-Lujano J; Flores-Villegas LV; Peñaloza-González JG; Torres-Nava JR; Espinosa-Elizondo RM; Amador-Sánchez R; Miranda-Madrazo MR; Santillán-Juárez JD; Pérez-Saldívar ML; Gurrola-Silva A; Orozco-Ruiz D; Solís-Labastida KA; Velázquez-Aviña MM; Duarte-Rodríguez DA; Mata-Rocha M; Sepúlveda-Robles OA; Ortiz-Maganda M; Bekker-Méndez VC; Jiménez-Morales S; Mejía-Aranguré JM; Rosas-Vargas H
Arch Med Res; 2021 May; 52(4):414-422. PubMed ID: 33541741
[TBL] [Abstract][Full Text] [Related]
16. Late relapsing childhood lymphoblastic leukemia.
Vora A; Frost L; Goodeve A; Wilson G; Ireland RM; Lilleyman J; Eden T; Peake I; Richards S
Blood; 1998 Oct; 92(7):2334-7. PubMed ID: 9746771
[TBL] [Abstract][Full Text] [Related]
17. Persistence of self-renewing leukemia cell progenitors during remission in children with B-precursor acute lymphoblastic leukemia.
Estrov Z; Ouspenskaia MV; Felix EA; McClain KL; Lee MS; Harris D; Pinkel DP; Zipf TF
Leukemia; 1994 Jan; 8(1):46-52. PubMed ID: 8289497
[TBL] [Abstract][Full Text] [Related]
18. Suppressors and activators of JAK-STAT signaling at diagnosis and relapse of acute lymphoblastic leukemia in Down syndrome.
Schwartzman O; Savino AM; Gombert M; Palmi C; Cario G; Schrappe M; Eckert C; von Stackelberg A; Huang JY; Hameiri-Grossman M; Avigad S; Te Kronnie G; Geron I; Birger Y; Rein A; Zarfati G; Fischer U; Mukamel Z; Stanulla M; Biondi A; Cazzaniga G; Vetere A; Wagner BK; Chen Z; Chen SJ; Tanay A; Borkhardt A; Izraeli S
Proc Natl Acad Sci U S A; 2017 May; 114(20):E4030-E4039. PubMed ID: 28461505
[TBL] [Abstract][Full Text] [Related]
19. The Landscape of Secondary Genetic Rearrangements in Pediatric Patients with B-Cell Acute Lymphoblastic Leukemia with t(12;21).
Kaczmarska A; Derebas J; Pinkosz M; Niedźwiecki M; Lejman M
Cells; 2023 Jan; 12(3):. PubMed ID: 36766699
[TBL] [Abstract][Full Text] [Related]
20. NSD2 E1099K drives relapse in pediatric acute lymphoblastic leukemia by disrupting 3D chromatin organization.
Narang S; Evensen NA; Saliba J; Pierro J; Loh ML; Brown PA; Kolekar P; Mulder H; Shao Y; Easton J; Ma X; Tsirigos A; Carroll WL
Genome Biol; 2023 Apr; 24(1):64. PubMed ID: 37016431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
